NEW YORK (GenomeWeb News) – Curetis today announced a distribution deal for its testing platform in Spain and Portugal with Laboratorios LETI.

The deal covers Curetis' Unyvero instruments and consumables and became effective on Jan. 1. Unyvero is expected to be launched in the region during the current quarter, Curetis said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.